JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB170099

重组Anti-p38 alpha/MAPK14抗体[E229]

Anti-p38 alpha/MAPK14 antibody [E229]

  • 20ul selling size
  • RabMAb
  • Recombinant
  • KO Validated
  • 了解详情

5

(4 Reviews)

|

(376 Publications)

Anti-p38 alpha/MAPK14 antibody [E229] (ab170099) is a rabbit monoclonal antibody detecting p38 alpha/MAPK14 in Western Blot, Flow Cytometry (Intra), Flow Cytometry, IP, ICC/IF. Suitable for Human, Mouse, Rat.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 260 publications

查看别名

CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A, MAPK14, Mitogen-activated protein kinase 14, MAP kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-binding protein, MAP kinase MXI2, MAX-interacting protein 2, Mitogen-activated protein kinase p38 alpha, Stress-activated protein kinase 2a, CSAID-binding protein, MAP kinase p38 alpha, SAPK2a

9 Images
Immunocytochemistry/ Immunofluorescence - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Immunocytochemistry/ Immunofluorescence analysis of HeLa(Human epithelial cell line from cervix adenocarcinoma) cells labeling p38 with ab170099 at 1/250. Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% tritonX-100. ab150077 an AlexaFluor®488 Goat anti-Rabbit IgG (1/1000) was used as the secondary antibody. The cells were co-stained with ab195889 an anti-alpha tubulin antibody [DM1A] microtubule marker (Alexa Fluor® 594) at 1/200. Nuclei counterstained with DAPI (blue).

Confocal image shows nuclear and cytoplasmic staining on HeLa cell line.

Flow Cytometry (Intracellular) - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Intracellular Flow Cytometry analysis ofHeLa cells labelling p38 with purified ab170099 at 1/40 (red). Cells were fixed with 4% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/500) was used as the secondary antibody. Black - Isotype control, rabbit monoclonal IgG. Blue - Unlabelled control, cells without incubation with primary and secondary antibodies.

Immunoprecipitation - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • IP

Unknown

Immunoprecipitation - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

ab170099 (purified) at 1/20 immunoprecipitating p38 in Jurkat whole cell lysate. 10 ug of cell lysate was present in the input. For western blotting, a HRP-conjugated Veriblot for IP Detection Reagent (ab131366) (1/1,500) was used for detection. A rabbit monoclonal IgG (ab172730) was used intead of ab128913 as a negative control (Lane 3).

Blocking buffer and concentration : 5% NFDM/TBST.

Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Immunoprecipitation - Anti-p38 alpha/MAPK14 antibody [E229] (ab170099)

Predicted band size: 41 kDa

false

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • WB

Lab

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : p38 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Jurkat cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab170099 observed at 40 kDa. Red - loading control, ab8245, observed at 37 kDa.

This western blot image is a comparison between ab170099 and a competitor's top cited rabbit polyclonal antibody.

All lanes:

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (ab170099)

Predicted band size: 41 kDa

false

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • WB

Unknown

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (ab170099) at 1/5000 dilution

Lane 1:

MCF-7 cell lysate at 20 µg

Lane 2:

HEK293 cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Predicted band size: 41 kDa

false

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • WB

Unknown

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (ab170099) at 1/5000 dilution

Lane 1:

Jurkat cell lysate at 10 µg

Lane 2:

HeLa cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Predicted band size: 41 kDa

false

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • WB

Unknown

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : p38 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : Jurkat cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab170099 observed at 40 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab170099 was shown to specifically react with p38 when p38 knockout samples were used. Wild-type and p38 knockout samples were subjected to SDS-PAGE. ab170099 and

ab8245 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.

All lanes:

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (ab170099)

Predicted band size: 41 kDa

false

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • WB

Unknown

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (ab170099) at 1/5000 dilution

All lanes:

C6 cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Predicted band size: 41 kDa

false

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)
  • WB

Unknown

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (AB170099)

Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.

All lanes:

Western blot - Anti-p38 alpha/MAPK14 antibody [E229] (ab170099) at 1/5000 dilution

Lane 1:

NIH/3T3 cell lysate at 20 µg

Lane 2:

3T3-L1 cell lysate at 20 µg

Lane 3:

PC-12 cell lysate at 20 µg

Secondary

Lanes 1 - 2:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/10000 dilution

Lane 3:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 20 µg

Predicted band size: 41 kDa

false

不同偶联物与剂型 (4)

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

E229

亚型

IgG

不含载体蛋白

No

反应种属

Mouse, Rat, Human

应用

Flow Cyt (Intra), IP, ICC/IF, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/10 - 1/100", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100 - 1/250", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/40", "FlowCytIntra-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/5000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "guaranteed", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

产品详情

What is this antibody validated in?
Anti-p38 alpha/MAPK14 antibody [E229] (ab170099) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat samples.

What is the molecular weight of p38 alpha/MAPK14?
Anti-p38 alpha/MAPK14 [E229] (ab170099) specifically detects a band for p38 alpha/MAPK14 (UniProt: Q16539) at a molecular weight of 42kDa.

Trusted by the scientific community
Anti-p38 alpha/MAPK14 [E229] (ab170099) was first used in a scientific publication in 2013 and has been cited over 260 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-p38 alpha/MAPK14 antibody [E229] (ab170099) has been confirmed by Western blot testing in MAPK14 Knockout HAP1 cells.

Other related products
We have a range of other formats of antibody clone [E229] also available for your convenience: ab170099, Alexa Fluor® 647 - ab209763, Alexa Fluor® 488 - ab210450, Alexa Fluor® 594 - ab210646, Carrier free - ab225534

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Stable for 12 months at -20°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

P38 alpha also known as MAPK14 is a significant member of the MAP kinase family involved in cellular response to stress signals. This protein has a molecular mass of about 38 kDa and is expressed in various tissues throughout the body. p38 alpha plays an important role in the signal transduction pathways that regulate inflammatory responses and cell differentiation. Its activity is modulated by multiple upstream kinases leading to cell-specific effects that are important for organismal homeostasis.
Biological function summary

P38 alpha MAPK14 is a part of a larger mitogen-activated protein kinase (MAPK) complex where it serves to mediate signals from external stressors to the appropriate cellular processes. It is particularly active in its roles involving inflammation and apoptosis regulation. The protein interacts with other members of the MAPK family and additional proteins such as TAB1 to conduct these biological signals efficiently.

Pathways

P38 alpha integrates into the p38 MAPK pathway and the NF-kB signaling pathway which are essential for managing cellular stress responses and inflammatory reactions. It closely interacts with other proteins like MKK3 and MKK6 which are directly upstream regulators phosphorylating and activating p38 MAPK14. This intricate connection allows p38 alpha to execute precise regulation within cellular environments.

P38 alpha MAPK14 is prominently associated with inflammatory diseases such as rheumatoid arthritis and cardiovascular disorders. In these conditions its aberrant activation or expression can lead to pathological inflammation and tissue damage. Additionally p38 alpha's connection with TNF-alpha in inflammation highlights its relevance in therapeutic targets for related disorders reflecting the significance of its modulation to potentially mitigate disease progression.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK14 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed : 9687510, PubMed : 9792677). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery (PubMed : 9687510, PubMed : 9792677). On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed : 11154262). MAPK14 interacts also with casein kinase II, leading to its activation through autophosphorylation and further phosphorylation of TP53/p53 (PubMed : 10747897). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. In a similar way, MAPK14 phosphorylates the ubiquitin ligase SIAH2, regulating its activity towards EGLN3 (PubMed : 17003045). MAPK14 may also inhibit the lysosomal degradation pathway of autophagy by interfering with the intracellular trafficking of the transmembrane protein ATG9 (PubMed : 19893488). Another function of MAPK14 is to regulate the endocytosis of membrane receptors by different mechanisms that impinge on the small GTPase RAB5A. In addition, clathrin-mediated EGFR internalization induced by inflammatory cytokines and UV irradiation depends on MAPK14-mediated phosphorylation of EGFR itself as well as of RAB5A effectors (PubMed : 16932740). Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17 (PubMed : 20188673). Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Another p38 MAPK substrate is FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed : 10330143, PubMed : 9430721, PubMed : 9858528). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates CDC25B and CDC25C which is required for binding to 14-3-3 proteins and leads to initiation of a G2 delay after ultraviolet radiation (PubMed : 11333986). Phosphorylates TIAR following DNA damage, releasing TIAR from GADD45A mRNA and preventing mRNA degradation (PubMed : 20932473). The p38 MAPKs may also have kinase-independent roles, which are thought to be due to the binding to targets in the absence of phosphorylation. Protein O-Glc-N-acylation catalyzed by the OGT is regulated by MAPK14, and, although OGT does not seem to be phosphorylated by MAPK14, their interaction increases upon MAPK14 activation induced by glucose deprivation. This interaction may regulate OGT activity by recruiting it to specific targets such as neurofilament H, stimulating its O-Glc-N-acylation. Required in mid-fetal development for the growth of embryo-derived blood vessels in the labyrinth layer of the placenta. Also plays an essential role in developmental and stress-induced erythropoiesis, through regulation of EPO gene expression (PubMed : 10943842). Isoform MXI2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform EXIP may play a role in the early onset of apoptosis. Phosphorylates S100A9 at 'Thr-113' (PubMed : 15905572). Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed : 35857590).. (Microbial infection) Activated by phosphorylation by M.tuberculosis EsxA in T-cells leading to inhibition of IFN-gamma production; phosphorylation is apparent within 15 minutes and is inhibited by kinase-specific inhibitors SB203580 and siRNA (PubMed : 21586573).
See full target information MAPK14

文献 (376)

Recent publications for all applications. Explore the full list and refine your search

Journal of inflammation research 18:13433-13452 PubMed41049072

2025

Dual Effects of Sodium Houttuyfonate Against Acute Rhinosinusitis: Antibacterial Action and Epithelial Barrier Repair Through the p38 MAPK/ERK Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Fang,Huixia Zhou,WeiYi Li,Lu Bai,Xinchen Sun,KaiYuan He,Shanshan Xue,Yongjun Wu

Frontiers in immunology 16:1629676 PubMed40995365

2025

Large extracellular vesicles derived from LPS-preconditioned cardiomyocytes alleviate myocarditis via mediating macrophage polarization and modulating p38 MAPK pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yanjie Jiang,Yingnan You,Yaxue Xie,Shan Zhou,Mengjie Ma,Bo Han

The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology : PubMed40947964

2025

Eupatilin alleviates right ventricular fibrosis in rats with pulmonary hypertension induced by monocrotaline.

Applications

Unspecified application

Species

Unspecified reactive species

Tonggang Zhu,Xue Xiao,Xue Li,Zhenkun Liu

Mediators of inflammation 2025:4932970 PubMed40918406

2025

Electroacupuncture Attenuates Hepatic Ischemia-Reperfusion Injury by Modulating the Esr1/TAK1-JNK/p38 Signaling Pathway in Rats.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaofang Fan,Wei Guo,Xiaodan Yang,Hao Zhang,Bruno Fink,Lingyu Hu,Xiaoguang Wang

International journal of ophthalmology 18:1426-1432 PubMed40827285

2025

Obtusifolin ameliorates dry eye model in rats by reducing inflammation and blocking MAPK/NF-κB pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Dan Zhu,Xiao-Yang Wu,Liang-Chang Li

Journal of nanobiotechnology 23:535 PubMed40696398

2025

A fibrin gel-loaded Gouqi-derived nanovesicle (GqDNV) repairs the heart after myocardial infarction by inhibiting p38 MAPK/NF-κB p65 pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Huan-Huan Zhou,Xiaolei Zhou,Jianqiu Pei,Shiyin Xu,Biyu Jin,Jiuling Chen,Zixuan Zhang,Mingmeng Tang,Yan Liu,Andreas K Nüssler,Liegang Liu,Qin Xu,Anxin Wang,Min Xia,Wei Yang

Acta pharmaceutica Sinica. B 15:3708-3724 PubMed40698146

2025

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury.

Applications

Unspecified application

Species

Unspecified reactive species

Yong Chen,Xue Yuan,Wei Yan,Yurong Zou,Haoche Wei,Yuhan Wei,Minghai Tang,Yulian Chen,Ziyan Ma,Tao Yang,Kongjun Liu,Baojian Xiong,Xiuying Hu,Jianhong Yang,Lijuan Chen

Cellular and molecular life sciences : CMLS 82:269 PubMed40610735

2025

Cell division cycle protein 42-driven activation of the MKK3/6-p38 signaling pathway participates in cardiac remodeling in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Ke Wen,Lin Xie,Quan-Wen Liu,Guan-Hui Yu,Xu-Hui Qiao,Yu-Chun Huang,Lu Wang,Xin Li,Li-Dan Wen,Xiao-Lei Wang,Jing He,Xin-Yu Xiao,Xiao-Xiao Zhao,Ling-Fang Wang,Hong-Bo Xin,Ke-Yu Deng

Hereditas 162:119 PubMed40604895

2025

TIMP1 promotes microglia M2 polarization through MAPK pathway to ameliorate early brain injury after ischemia.

Applications

Unspecified application

Species

Unspecified reactive species

Kangkang Zhao,Zizhao Huang

International journal of molecular sciences 26: PubMed40565375

2025

Isostrictiniin Alleviates LPS-Induced Acute Lung Injury via the Regulation of the Keap1-Nrf2/HO-1 and MAPK/NF-κB Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Wanting Ding,Yuan Sun,Wulipan Tuohudaali,Chenyang Li,Yuhan Yao,Jun Zhao
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com